April 8, 2019
Audentes Expands Platform and Pipeline with Programs for DMD and DM
Read More
June 26, 2017
First Duchenne Muscular Dystrophy Boy in Canada to Begin Drisapersen Redosing
Read More
June 23, 2017
RARECast: Summit Pursues A Different Approach to Treating Duchenne
Read More
June 23, 2017
Rare Disease Report: RASRx is the Latest Duchenne Drug To Get Orphan Status From the FDA
Read More
June 7, 2017
CD Access to Provide Special Access Program for Duchenne Muscular Dystrophy Patients in Canada
Read More
May 8, 2017
Michael’s Cause Has Cause for Celebration After Golf Fundraiser
Read More
March 30, 2017
Leader in Cure, Care and Community for Duchenne Muscular Dystrophy CureDuchenne Launches New Website
Read More
February 21, 2017
CureDuchenne Applauds the FDA Approval of Marathon’s EMFLAZA (deflazacort) for the Treatment of Duchenne Muscular Dystrophy
Read More
January 23, 2017
CureDuchenne Creates New Program to Improve PT Training and Clinical Trial Education
Read More
January 19, 2017
Why Health Insurers Won't Cover this $300,000-a-year Rare Disease Drug
Read More
December 1, 2016
CureDuchenne Aims for a Treatment for the 87%
Read More
November 11, 2016
RARECast: Discovering the Creative Use of Outrage
Read More
Load More
X